Hide Studies Not Open or Pending
Condition(s):Relapsed Multiple Myeloma; Refractory Multiple MyelomaLast Updated:March 9, 2022Completed
Condition(s):Relapsed and Refractory Multiple MyelomaLast Updated:November 14, 2022Not yet recruiting
Condition(s):Relapsed or Refractory Multiple MyelomaLast Updated:February 7, 2022Recruiting
Condition(s):Multiple MyelomaLast Updated:November 18, 2019Unknown status
Condition(s):Relapsed and Refractory Multiple MyelomaLast Updated:August 1, 2022Recruiting
Condition(s):Hematologic MalignanciesLast Updated:January 30, 2023Recruiting
Condition(s):CS1+ or BCMA+ Multiple MyelomaLast Updated:February 1, 2023Recruiting
Condition(s):Relapsed/Refractory Multiple MyelomaLast Updated:October 28, 2022Terminated
Condition(s):Multiple Myeloma, RefractoryLast Updated:January 27, 2023Withdrawn
Condition(s):Refractory Multiple MyelomaLast Updated:March 8, 2022Terminated
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.